Next report date
Report period
Q3 2023
EPS estimate
−0.06USD
Revenue estimate
35.77 MUSD
−99.56 MUSD
103.27 MUSD
30.00 M
About Lifecore Biomedical, Inc.
Sector
CEO
James G. Hall
Headquarters
Chaska
Website
Employees (FY)
459
Founded
1986
FIGI
BBG000G1FS10
Lifecore Biomedical, Inc. is a contract development and manufacturing organization, which engages in the provision of differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It operates through the following business segments: Lifecore, Curation Foods, and Others. The Lifecore segment focuses on selling products utilizing hyaluronan, a naturally occurring polysaccharide that is widely distributed in the extracellular matrix of connective tissues in both animals and humans, and non-HA products for medical use primarily in the Ophthalmic, Orthopedic and other markets. The Curation Foods segment is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels. The Others segment is Corporate, which includes corporate general and administrative expenses, Non Lifecore and non-Curation Food interest income, interest expense, and income tax expenses. The company was founded by Ray Stewart on October 31, 1986 and is headquartered in Chaska, MN.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of LFCR is 6.60 USD — it has decreased by 0.68% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Lifecore Biomedical, Inc. stocks are traded under the ticker LFCR.
Lifecore Biomedical, Inc. is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
LFCR stock is 4.66% volatile and has beta coefficient of −0.15. Check out the list of the most volatile stocks — is Lifecore Biomedical, Inc. there?
LFCR earnings for the last quarter are −0.33 USD per share, whereas the estimation was −0.23 USD resulting in a −43.48% surprise. The estimated earnings for the next quarter are −0.13 USD per share. See more details about Lifecore Biomedical, Inc. earnings.
Lifecore Biomedical, Inc. revenue for the last quarter amounts to 24.80 M USD despite the estimated figure of 24.55 M USD. In the next quarter revenue is expected to reach 29.85 M USD.
Yes, you can track Lifecore Biomedical, Inc. financials in yearly and quarterly reports right on TradingView.
LFCR stock has risen by 3.53% compared to the previous week, the month change is a 29.31% rise, over the last year Lifecore Biomedical, Inc. has showed a 56.28% increase.
Today Lifecore Biomedical, Inc. has the market capitalization of 202.83 M, it has decreased by 3.82% over the last week.
No, LFCR doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LFCR shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Lifecore Biomedical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 459.00 employees. See our rating of the largest employees — is Lifecore Biomedical, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Lifecore Biomedical, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Lifecore Biomedical, Inc. stock shows the sell signal. See more of Lifecore Biomedical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Lifecore Biomedical, Inc. future price: according to them, LFCR price has a max estimate of 6.00 USD and a min estimate of 6.00 USD. Read a more detailed Lifecore Biomedical, Inc. forecast: see what analysts think of Lifecore Biomedical, Inc. and suggest that you do with its stocks.